jueves, 14 de mayo de 2026

75 Campaigning to improve sepsis recognition and outcomes The Lancet Respiratory Medicine +++ +...

Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study Jorge F Maspero, MDa Send email to jorge.maspero@fundacioncidea.org.ar ∙ Prof Ian D Pavord, FMedScib ∙ Prof Michael E Wechsler, MDc ∙ Prof William Busse, MDd ∙ Tanya M Laidlaw, MDe ∙ Prof Robert M Mróz, MDf ∙ et al. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00439-4/abstract?utm_campaign=update-lanres&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanres&_hsenc=p2ANqtz-_Pr-_KefPMT-LvXaCtyLZJZfwzJShPB0uClxMIDXOSB3WCu63raL3wo3Fnn5nOKb_OlLn8E0FgYMHiNRO3uLgpNya-7Q&_hsmi=418237343&utm_content=418181016&utm_source=hs_email Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial Prof Malcolm G Semple, PhDa,b Send email to m.g.semple@liverpool.ac.uk ∙ Chloe Donohue, BScc ∙ Laura Price, BScc ∙ Rachael Cooper, MScc ∙ Carly Vaughan, BScc ∙ Tracy Moittc ∙ et al. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00008-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanres&utm_campaign=update-lanres&utm_medium=email&_hsenc=p2ANqtz--GoterIKSBcRCfWoyN0rrH4H24DY0404jBB4ilLH5AvHXe-iCFVzPwiH0E2-qzZrrifSuwXgZOlcq2h6jQ63_-vzuDAA&_hsmi=418237343&utm_content=418181016&utm_source=hs_email Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial Prof Javier A Neyra, MDa ∙ Prof Matthieu Legrand, MDb Send email to matthieu.legrand@ucsf.edu ∙ Prof Mark A Tidswell, MDd ∙ Prof Ali Al-Khafaji, MDe ∙ Claude Galphin, MDf ∙ Ronald Rains, MDg ∙ et al. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00047-0/fulltext?dgcid=hubspot_update_feature_updatealerts_lanres&utm_campaign=update-lanres&utm_medium=email&_hsenc=p2ANqtz-8Op9LFNte6ILPL6u-Bk4hCzosvuXWgQNHXtGjxIV3pIILtqfO4VWr9FAAk_GyHjVq7YbOKMZuDQj9AYbwjg-DuQN23Wg&_hsmi=418237343&utm_content=418181016&utm_source=hs_email Editorial p375 Campaigning to improve sepsis recognition and outcomes The Lancet Respiratory Medicine https://www.thelancet.com/journals/lanres/issue/vol14no5/PIIS2213-2600(26)X2004-5

No hay comentarios:

Publicar un comentario